Abstract
In the present work, an attempt was made to develop and evaluate composite microspheres for controlled release of an anti-diabetic drug, nateglinide (NTG). The composite microspheres were prepared using rosin gum and ethyl cellulose as retardant polymers for drug release by solvent evaporation method. DSC and XRD analysis indicated the uniform dispersion of drug in the microspheres. The microspheres were capable of releasing drug for 24 h and the drug release mechanism followed non-Fickian transport. In vivo anti-diabetic activity conducted on wistar rats indicated that the plain (unformulated) NTG showed maximum percent reduction in blood glucose up to 2 h and then the blood glucose was increased. While in case of rats treated with test microspheres (RN6), the percent reduction in glucose level was slow up to 2 h as compared to plain drug, then it was gradually increased to 72.83 % at the end of 24 h. Histopathology of rat pancreas suggested that the regeneration of β cells was seen in the rats treated with RN6 microspheres. It can be concluded from the study that, the prepared microspheres are versatile delivery systems for nateglinide, which could release drug for longer period of time.
Keywords: Controlled release, ethyl cellulose, microspheres, nateglinide, rosin gum.
Drug Delivery Letters
Title:Composite Microspheres of Rosin Gum and Ethyl cellulose for Controlled Release of an Anti-diabetic Drug: in-vitro and in-vivo Assessment
Volume: 4 Issue: 3
Author(s): Kumari Niharika, Hanakunti M. Nanjappaiah, Akram A. Naikawadi and Raghavendra V. Kulkarni
Affiliation:
Keywords: Controlled release, ethyl cellulose, microspheres, nateglinide, rosin gum.
Abstract: In the present work, an attempt was made to develop and evaluate composite microspheres for controlled release of an anti-diabetic drug, nateglinide (NTG). The composite microspheres were prepared using rosin gum and ethyl cellulose as retardant polymers for drug release by solvent evaporation method. DSC and XRD analysis indicated the uniform dispersion of drug in the microspheres. The microspheres were capable of releasing drug for 24 h and the drug release mechanism followed non-Fickian transport. In vivo anti-diabetic activity conducted on wistar rats indicated that the plain (unformulated) NTG showed maximum percent reduction in blood glucose up to 2 h and then the blood glucose was increased. While in case of rats treated with test microspheres (RN6), the percent reduction in glucose level was slow up to 2 h as compared to plain drug, then it was gradually increased to 72.83 % at the end of 24 h. Histopathology of rat pancreas suggested that the regeneration of β cells was seen in the rats treated with RN6 microspheres. It can be concluded from the study that, the prepared microspheres are versatile delivery systems for nateglinide, which could release drug for longer period of time.
Export Options
About this article
Cite this article as:
Niharika Kumari, M. Nanjappaiah Hanakunti, A. Naikawadi Akram and V. Kulkarni Raghavendra, Composite Microspheres of Rosin Gum and Ethyl cellulose for Controlled Release of an Anti-diabetic Drug: in-vitro and in-vivo Assessment, Drug Delivery Letters 2014; 4 (3) . https://dx.doi.org/10.2174/2210303104666140909004015
DOI https://dx.doi.org/10.2174/2210303104666140909004015 |
Print ISSN 2210-3031 |
Publisher Name Bentham Science Publisher |
Online ISSN 2210-304X |
Call for Papers in Thematic Issues
Nanomaterial Assisted Targeted Therapies for Chronic Disorders- Preclinical to Clinical Outcomes
In recent years, the integration of nanomaterials into therapeutic strategies has emerged as a promising avenue in the pursuit of more effective treatments for chronic disorders. This dynamic field, explored in the context of "Nanomaterial Assisted Targeted Therapies for Chronic Disorders - Preclinical to Clinical Outcomes," seeks to bridge the ...read more
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
Related Articles
-
Dietary Compounds, Epigenetic Modifications and Metabolic Diseases
Current Chemical Biology Regulation of Insulin Synthesis and Secretion and Pancreatic Beta-Cell Dysfunction in Diabetes
Current Diabetes Reviews Preparation and Evaluation of Buccal Bioadhesive Tablets Containing Clotrimazole
Current Drug Delivery Nonalcoholic Fatty Liver Disease: The Pathogenetic Roles of Insulin Resistance and Adipocytokines
Current Molecular Medicine Irbesartan and Hydrochlorothiazide Association in the Treatment of Hypertension
Current Vascular Pharmacology Celiac Disease: An Emerging Epidemic
Current Nutrition & Food Science Physiology of Islet Engraftment
Immunology, Endocrine & Metabolic Agents in Medicinal Chemistry (Discontinued) Catheter Ablation of Lone Atrial Fibrillation
Current Pharmaceutical Design Lassa Virus Genome
Current Genomics Thiazoles and Thiazolidinones as Antioxidants
Current Medicinal Chemistry An Update on Clinical and Pharmacological Aspects of Drug-Eluting Stents
Cardiovascular & Hematological Disorders-Drug Targets Cognitive Dysfunction in Depression – Pathophysiology and Novel Targets
CNS & Neurological Disorders - Drug Targets Exploitation of Some Natural Products for the Prevention and/or Nutritional Treatment of SARS-CoV2 Infection
Endocrine, Metabolic & Immune Disorders - Drug Targets Stem Cells: A Review Encompassing the Literature with a Special Focus on the Side-Lined Miraculous Panacea; Pre-Morula Stem Cells
Current Stem Cell Research & Therapy Flow Cytometry Study of Leukocyte Function: Analytical Comparison of Methods and their Applicability to Clinical Research
Current Medicinal Chemistry Inhibition of 2C Coxsackie B Virus Protein to Decrease Pathogenicity of Diabetes Mellitus Type 1
Current Computer-Aided Drug Design Significance of Aspirin and Clopidogrel Resistance in Patients Undergoing Percutaneous Coronary Interventions
Current Vascular Pharmacology Role of Advanced Glycation End Products (AGEs) and Oxidative Stress in Diabetic Retinopathy
Current Pharmaceutical Design Myocardial Revascularization Strategies in Diabetic Patients with Multi-Vessel Disease: CABG vs DES-Based PCI
Current Pharmaceutical Design Calcium Channel Blockers in Restoration of Endothelial Function: Systematic Review and Meta-Analysis of Randomized Controlled Trials
Current Medicinal Chemistry